Mar 28, 2019
56:55
For every 55 shares held, investors received 56. The price per share adjusted from $0.06 to $0.06.
The split itself did not change the total investment value.
Prescient Therapeutics Limited (ASX:PTX) operates in the Biotechnology industry.
Prescient Therapeutics Limited company overviewPrescient Therapeutics Limited's most recent stock split was on March 28, 2019. It was a 56-for-55 forward split, so shareholders received 56 shares for every 55 they held.
Prescient Therapeutics Limited (ASX:PTX) has split its stock 9 times: a 1-for-2 reverse split on September 27, 1996, a 20-for-19 split on July 17, 1997, a 513-for-500 split on September 18, 2002, a 1017-for-1000 split on November 29, 2005, a 36-for-35 split on May 27, 2011, a 1-for-10 reverse split on September 4, 2013, a 1-for-20 reverse split on December 2, 2014, a 40-for-39 split on May 25, 2016, and a 56-for-55 split on March 28, 2019.
Prescient Therapeutics Limited has split its stock 9 times. This history records 9 splits between September 27, 1996 and March 28, 2019.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Prescient Therapeutics Limited's 56-for-55 split on March 28, 2019, every 55 shares became 56 shares.
Prescient Therapeutics Limited has not announced a new split in our records. Its most recent split was on March 28, 2019, 7 years ago. Companies announce splits in advance, and any new ASX:PTX split will appear on this page.
Already premium?